TERF2 and cancer: Genetic variations in nine telomere maintenance pathways, including telomeric repeat-binding factor 2 (TRF2), SNVs and indels associated with telomere maintenance genes and known cancer drug response; presence of CNAs in 11 different pathways, including the DNA damage repair (DDR) pathway